Will Sawyer

438 total citations
12 papers, 311 citations indexed

About

Will Sawyer is a scholar working on Infectious Diseases, Virology and Urology. According to data from OpenAlex, Will Sawyer has authored 12 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Virology and 3 papers in Urology. Recurrent topics in Will Sawyer's work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (7 papers) and HIV/AIDS Research and Interventions (4 papers). Will Sawyer is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (7 papers) and HIV/AIDS Research and Interventions (4 papers). Will Sawyer collaborates with scholars based in United Kingdom, Netherlands and Denmark. Will Sawyer's co-authors include Andrew Hill, Brian Gazzard, Jasper van der Lugt, Graeme Moyle, Marta Boffito, Andrew Hill, Janaki Amin, Matthew Law, Adam Lloyd and Richard Kennedy and has published in prestigious journals such as The Journal of Urology, European Urology and Fertility and Sterility.

In The Last Decade

Will Sawyer

12 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Will Sawyer United Kingdom 9 186 137 87 47 46 12 311
Ana Barrios Spain 10 243 1.3× 194 1.4× 83 1.0× 18 0.4× 4 0.1× 19 371
Regina Kuhmmer Brazil 13 96 0.5× 92 0.7× 110 1.3× 15 0.3× 17 303
Rosmeri Kuhmmer Lazzaretti Brazil 13 104 0.6× 95 0.7× 114 1.3× 14 0.3× 18 298
Michael Basar United States 6 211 1.1× 149 1.1× 204 2.3× 33 0.7× 8 334
Lumine Na Australia 8 145 0.8× 87 0.6× 73 0.8× 16 0.3× 12 312
Sara Bañón Spain 11 152 0.8× 87 0.6× 150 1.7× 34 0.7× 24 308
Lloyd Curtis United States 8 358 1.9× 285 2.1× 206 2.4× 14 0.3× 12 498
Ivy I Boydstun United States 4 378 2.0× 114 0.8× 287 3.3× 24 0.5× 7 507
Gema González‐Pardo Spain 7 348 1.9× 169 1.2× 112 1.3× 97 2.1× 9 454
Inmaculada Jiménez-Nàcher Spain 9 246 1.3× 86 0.6× 42 0.5× 45 1.0× 1 0.0× 19 471

Countries citing papers authored by Will Sawyer

Since Specialization
Citations

This map shows the geographic impact of Will Sawyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Will Sawyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Will Sawyer more than expected).

Fields of papers citing papers by Will Sawyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Will Sawyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Will Sawyer. The network helps show where Will Sawyer may publish in the future.

Co-authorship network of co-authors of Will Sawyer

This figure shows the co-authorship network connecting the top 25 collaborators of Will Sawyer. A scholar is included among the top collaborators of Will Sawyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Will Sawyer. Will Sawyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Klarskov, Niels, et al.. (2019). Effect of a 5‐HT2c receptor agonist on urethral closure mechanism in healthy women. Neurourology and Urodynamics. 38(6). 1700–1706. 4 indexed citations
2.
Newgreen, Donald, R. Besuyen, Robert Snijder, et al.. (2017). Long-Term Safety and Efficacy of Solifenacin in Children and Adolescents with Overactive Bladder. The Journal of Urology. 198(4). 928–936. 15 indexed citations
3.
Newgreen, Donald, et al.. (2016). Solifenacin in Children and Adolescents with Overactive Bladder: Results of a Phase 3 Randomised Clinical Trial. European Urology. 71(3). 483–490. 27 indexed citations
4.
Arribas, José María, José Ignacio Bernardino, A.D. Hill, et al.. (2012). Effects of switching to PI monotherapy on measures of lipoatrophy: meta‐analysis of six randomized HIV clinical trials. Journal of the International AIDS Society. 15(S4). 1–1. 1 indexed citations
5.
Hill, Andrew, Will Sawyer, & Brian Gazzard. (2009). Effects of First-Line Use of Nucleoside Analogues, Efavirenz, and Ritonavir-Boosted Protease Inhibitors on Lipid Levels. HIV Clinical Trials. 10(1). 1–12. 42 indexed citations
6.
7.
Hill, Andrew, Will Sawyer, & Brian Gazzard. (2009). Effects of First-Line Use of Nucleoside Analogues, Efavirenz, and Ritonavir-Boosted Protease Inhibitors on Lipid Levels. HIV Clinical Trials. 10(1). 1–12. 37 indexed citations
8.
Hill, Andrew, Jasper van der Lugt, Will Sawyer, & Marta Boffito. (2009). How much ritonavir is needed to boost protease inhibitors? Systematic review of 17 dose-ranging pharmacokinetic trials. AIDS. 23(17). 2237–2245. 50 indexed citations
9.
Gupta, Ravi, Andrew Hill, Will Sawyer, & Deenan Pillay. (2008). Emergence of drug resistance in hiv-1 infected patients after first-line highly active antiretroviral therapy (haart): a systematic review of clinical trials. Journal of Infection. 57(5). 430–431. 1 indexed citations
10.
Moyle, Graeme, Will Sawyer, Matthew Law, Janaki Amin, & Andrew Hill. (2004). Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: A meta-analysis of six prospective, randomized, comparative studies. Clinical Therapeutics. 26(1). 92–97. 65 indexed citations
11.
Lloyd, Adam, Richard Kennedy, Julia Hutchinson, & Will Sawyer. (2003). Economic evaluation of highly purified menotropin compared with recombinant follicle-stimulating hormone in assisted reproduction. Fertility and Sterility. 80(5). 1108–1113. 28 indexed citations
12.
Lacey, L.F., Josephine Mauskopf, Richard C. Lindrooth, et al.. (1999). A Prospective Cost-Consequence Analysis of Adding Lamivudine to Zidovudine-Containing Antiretroviral Treatment Regimens for HIV Infection in the US. PharmacoEconomics. 15(Supplement 1). 23–37. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana Barrios Breakdown of academic impact, for papers by Regina Kuhmmer Breakdown of academic impact, for papers by Rosmeri Kuhmmer Lazzaretti Breakdown of academic impact, for papers by Michael Basar Breakdown of academic impact, for papers by Lumine Na Breakdown of academic impact, for papers by Sara Bañón Breakdown of academic impact, for papers by Lloyd Curtis Breakdown of academic impact, for papers by Ivy I Boydstun Breakdown of academic impact, for papers by Gema González‐Pardo Breakdown of academic impact, for papers by Inmaculada Jiménez-Nàcher
Rankless by CCL
2026